This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
BASES-MOLECULAR GENETIC spinocerebellar ataxias: IDENTIFICATION OF DEFICITS GROUNDS, BIOMARKERS AND THERAPEUTIC TARGETS Investments < €500k Spain 2016
DISCRIMINATION AND MARKERS FOR REGIONAL VULNERABILITY FACTORS IN NEURONAL AGING neurodegeneration associated normal and pathological CNS Investments < €500k Spain 2016
ESTABLISHMENT OF A MITOCHONDRIAL ALGORITHM TO PREDICT THE RISK OF PROGRESSION TO ALZHEIMER’S DISEASE IN PATIENTS WITH LOW COGNITIVE IMPAIRMENT Investments < €500k Spain 2016
CONVERGING MECHANISMS BETWEEN AUTOPHAGIA AND AXONAL FUNCTION AND METABOLIC INFLUENCE IN THE REGULATION OF NEURODEGENERATIVE DISEASES Investments < €500k Spain 2016
INDIVIDUAL DIFFERENCES IN LONGITUDINAL CHANGES IN FUNCTIONAL AND STRUCTURAL CONNECTIVITY IN PRE-SYMPTOMATIC PATIENTS OF HUNTINGTON DISEASE Investments < €500k Spain 2016
PARKINSON DISEASE AND COGNITIVE IMPAIRMENT: IDENTIFICATION OF PREDICTIVE GENETIC MARKERS BY MASS SEQUENCING. Investments < €500k Spain 2016
BIOCHEMICAL AND NEUROIMAGEN STUDY OF PRE-AMYLOIDOGENIC CHANGES IN ALZHEIMER’S PRECLINIC DISEASE; ANALYSIS OF CEREBRAL LIPIDOMIC AND MICROSTRUCTURE OF NEUROCOGNITIVE NETWORKS Investments < €500k Spain 2016
ANKK1 IN THE DOPAMINERGIC SYSTEM: IMPLICATION IN ETIOLOGY AND IMPULSIVE RISKS IN PARKINSON’S DISEASE Investments < €500k Spain 2016
ADVANCING DIAGNOSIS, PROGNOSIS AND THE THERAPY OF RARE NEURODEGENERATIVE DISEASES Investments < €500k Spain 2016
ROLE OF ANKK1 in genetics and pathophysiology of the disease PARKINSON’s disease Investments < €500k Spain 2016
